| 000 | 01775 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516113930.0 | ||
| 264 | 0 | _c20130429 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1556-679X | ||
| 024 | 7 |
_a10.1128/CVI.00473-12 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFujii, Jun | |
| 245 | 0 | 0 |
_aProtection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice. _h[electronic resource] |
| 260 |
_bClinical and vaccine immunology : CVI _cDec 2012 |
||
| 300 |
_a1932-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBCG Vaccine _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xprevention & control |
| 650 | 0 | 4 |
_aEscherichia coli Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aShiga Toxin 2 _xgenetics |
| 650 | 0 | 4 |
_aShiga-Toxigenic Escherichia coli _xgenetics |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xadministration & dosage |
| 700 | 1 | _aNaito, Mariko | |
| 700 | 1 | _aYutsudo, Takashi | |
| 700 | 1 | _aMatsumoto, Sohkichi | |
| 700 | 1 | _aHeatherly, Daniel P | |
| 700 | 1 | _aYamada, Takeshi | |
| 700 | 1 | _aKobayashi, Hideyuki | |
| 700 | 1 | _aYoshida, Shin-Ichi | |
| 700 | 1 | _aObrig, Tom | |
| 773 | 0 |
_tClinical and vaccine immunology : CVI _gvol. 19 _gno. 12 _gp. 1932-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/CVI.00473-12 _zAvailable from publisher's website |
| 999 |
_c22157164 _d22157164 |
||